{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?nctId=NCT02403193",
    "query": {
      "nctId": "NCT02403193"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 1,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-09-03T20:52:49.222Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT02403193",
      "title": "Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        {
          "name": "PBF-509_80 mg",
          "type": "DRUG"
        },
        {
          "name": "PBF-509_160 mg",
          "type": "DRUG"
        },
        {
          "name": "PBF-509_320 mg",
          "type": "DRUG"
        },
        {
          "name": "PBF-509_640 mg",
          "type": "DRUG"
        },
        {
          "name": "Combo PBF-509 (160 mg) + PDR001",
          "type": "DRUG"
        },
        {
          "name": "Combo PBF-509 (320 mg) + PDR001",
          "type": "DRUG"
        },
        {
          "name": "Combo PBF-509 (640 mg) + PDR001",
          "type": "DRUG"
        },
        {
          "name": "RP2D (PBF-509+PDR001)_immuno naïve",
          "type": "DRUG"
        },
        {
          "name": "Experimental: RP2D (PBF-509+PDR001)_immuno treated",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Palobiofarma SL",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 92,
      "start_date": "2015-10",
      "completion_date": "2021-11-24",
      "has_results": false,
      "last_update_posted_date": "2022-01-12",
      "last_synced_at": "2026-09-03T20:52:49.222Z",
      "location_count": 1,
      "location_summary": "Tampa, Florida",
      "locations": [
        {
          "city": "Tampa",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02403193"
    }
  ]
}